Anchyra Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Sell
4,843
-210
-4% -$58.1K 0.26% 78
2026
Q1
$1.49M Buy
5,053
+73
+1% +$21.7K 0.45% 45
2025
Q4
$1.36M Buy
+4,980
New +$1.35M 0.42% 47

Other funds holding CME

Anchyra Partners's CME Position: Q2 2026 in Review

Anchyra Partners reduced its CME Group (CME) stake by 4.2% in Q2 2026, selling an estimated $58.1K and leaving 4,843 shares worth $1.07M. The position accounts for 0.26% of the portfolio, ranked #78.

Anchyra Partners first reported a position in CME in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.49M in Q1 2026. 956 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Anchyra Partners held 4,843 shares of CME Group worth $1.07M as of Q2 2026.
  • Anchyra Partners sold 210 CME Group shares in Q2 2026, an estimated $58.1K.
  • CME Group made up 0.26% of Anchyra Partners's portfolio in Q2 2026, its #78 holding.
  • Anchyra Partners first reported a position in CME Group in Q4 2025 and has held it in 3 quarters since.
  • Anchyra Partners's CME Group position peaked at $1.49M in Q1 2026.
  • 956 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Anchyra Partners's 13F filing for Q2 2026, filed 23 Jul 2026.